Share on

click on the image above to watch the webcast
(to view the webcast in fullscreen, click on the bottom right square icon underneath the YouTube logo)

In this video, IMF Chairman Brian G.M. Durie moderates a lively discussion about MRD in the Relapse setting with Dr. Joseph Mikhael (IMF Chief Medical Officer) and Dr. Maria Victoria Mateos (University of Salamanca, Spain).

This video is the sixth in a six-part series that focuses on making sense of multiple myeloma treatment based upon the newly obtained input from the American Society of Hematology (ASH) 60th annual convention which took place in San Diego, CA on December 2018.

Other Topics:


With support from:
Celgene, Karyopharm Therapeutics, and Takeda Oncology

 

Previous Post
Blood Monitoring
Next Post
Deep and Durable Responses with Oral Selinexor Plus Low Dose Dexamethasone in Patients with Penta Exposed and Triple Class-Refractory MM

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.